Randomized Trialhigh evidence
Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial.
Circulation·June 15, 2026·PMID 42290366
Why it mattersA minimal-stenting approach using a novel sirolimus-eluting balloon could reduce long-term stent-related complications, but the higher revascularization rate and borderline noninferiority results warrant cautious interpretation.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled